Probing the Histamine H 1 Receptor Binding Site to Explore Ligand Binding Kinetics
Journal of Medicinal Chemistry · 09.01.2025 · 68 (1) · 448-464
DOI: 10.1021/acs.jmedchem.4c02043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.12.2024. Verfasst von Sebastiaan Kuhne und 9 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam Institute of Molecular and Life Sciences (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boe…. Hauptthemen laut MEDLINE: Receptors, Histamine H1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative, European Cooperation in Science and Technology.
Abstract (Originalsprache)
Analysis of structure-kinetic relationships (SKR) can contribute to an improved understanding of receptor-ligand interactions. Here, fragment 1 (4-(2-benzylphenoxy)-1-methylpiperidine) was used in different fragment growing approaches to mimic the putative binding mode of the long residence time (RT) ligands olopatadine, acrivastine, and levocetirizine at the histamine H1 receptor (H1R). SKR analyses reveal that introduction of a carboxylic acid moiety can increase RT at H1R up to 11-fold. Ligand efficiency (LE) decreases upon the introduction of the negatively charged group, whereas kinetic efficiency (KE) increases up to 8.5-fold. The olopatadine/acrivastine mimics give up to 15-fold differences in the RT, while the levocetirizine mimics afford similar RTs with only a 3-fold difference. Therefore, the levocetirizine mimics are less sensitive to structural changes. This study illustrates that for H1R, there are several ways to increase RT but the different strategies differ significantly in SKR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Amsterdam Institute of Molecular and Life Sciences (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands.
ORCID-Profile: Henry F Vischer, Chris de Graaf, Maikel Wijtmans, Rob Leurs, Iwan J P de Esch
Förderung
- Innovative Medicines Initiative
- European Cooperation in Science and Technology
Zitieren
APA
Kuhne, S., Bosma, R., Kooistra, A. J., Riemens, R., Stroet, M. C. M., Vischer, H. F., de Graaf, C., Wijtmans, M., Leurs, R., & de Esch, I. J. P. (2025). Probing the Histamine H 1 Receptor Binding Site to Explore Ligand Binding Kinetics. Journal of Medicinal Chemistry, 68(1), 448-464. https://doi.org/10.1021/acs.jmedchem.4c02043
Vancouver
Kuhne S, Bosma R, Kooistra AJ, Riemens R, Stroet MCM, Vischer HF, et al. Probing the Histamine H 1 Receptor Binding Site to Explore Ligand Binding Kinetics. Journal of Medicinal Chemistry. 2025;68(1):448-464. doi:10.1021/acs.jmedchem.4c02043
BibTeX
@article{Kuhne2025,
author = {Kuhne, Sebastiaan and Bosma, Reggie and Kooistra, Albert J and Riemens, Rick and Stroet, Marc C M and Vischer, Henry F and de Graaf, Chris and Wijtmans, Maikel and Leurs, Rob and de Esch, Iwan J P},
title = {Probing the Histamine H 1 Receptor Binding Site to Explore Ligand Binding Kinetics},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {1},
pages = {448--464},
doi = {10.1021/acs.jmedchem.4c02043}
}
EUVIMED